HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?

Search
EmailWire News Links

Home > News By Company > Lawyer Central

Print e mail rss del
Y! myWeb


Gadolinium MRI Contrast Dye Information Provided by Lawyer Central

Lawyer Central has recently updated its Gadolinium Contrast Dye Resource Center, which provides information to consumers about the risks associated with the use of gadolinium based MRI contrast dyes.

(EMAILWIRE.COM, February 05, 2009 ) New York, NY - Lawyer Central has recently updated its Gadolinium Contrast Dye Resource Center, which provides information to consumers about the risks associated with the use of gadolinium based MRI contrast dyes. Although gadolinium contrast dyes pose no serious risk for most individuals, those with kidney problems may be unable to quickly eliminate the gadolinium from their bodies following the contrast dye injection for an MRI. This prolonged exposure to gadolinium can lead to the development of a condition known as Nephrogenic Systemic Fibrosis (NSF).

Before the recent discovery of the potential side effects of gadolinium, doctors praised the element because it allowed for enhanced imaging in MRIs. Gadolinium produces a visible contrast in blood vessels, organs and tissues, which aids medical professionals in detecting tumors or abnormal tissues. In the United States, gadolinium was manufactured by GE Healthcare, Bayer HealthCare Pharmaceuticals, Tyco/Mallinckrodt and Bracco Diagnostics under the following brand names: Magnevist, MultiHance, Omniscan, OptiMARK and ProHance.

Although gadolinium has useful properties in the medical field, it also poses health risks for patients with kidney conditions. Recent studies have shown a link between gadolinium and NSF, the potentially life-threatening disease that causes fibrosis of the skin, eyes, joints and internal organs. The first diagnosis of Nephrogenic Systemic Fibrosis occurred in 1997. In serious cases, it can lead to immobility and breathing difficulties, with the potential to be fatal. This is a relatively new disease and no cure has been discovered yet. The Food and Drug Administration (FDA) issued three warnings about the effects of gadolinium between June 2006 and May 2007. In addition, several lawsuits have been filed aimed at the manufacturers of gadolinium contrast dye alleging that these manufacturers failed to warn consumers about its risks and failed to adequately test it.

To learn more about gadolinium and NSF, visit http://injury.lawyercentral.com/Gadolinium-Contrast-Dye-Lawyers-Attorneys--1-106.html. Lawyer Central’s gadolinium lawyers are offering a free case evaluation for individuals who have developed NSF as a result of gadolinium exposure. If you are interested in learning about the legal rights of individuals who have been harmed by gadolinium, fill out the form on the right side of the page. Gadolinium attorneys can advise you of your legal options and help you get the justice you deserve.

About Lawyer Central

The Lawyer Central Network is an exclusive nationwide network of attorneys highly dedicated to their unique areas of practice, including gadolinium contrast dye litigation. Lawyer Central is emerging as the leading public relations and mixed media marketing organization for fast-growing law firms and forward-thinking attorneys. Lawyer Central membership includes a variety of media exposure ranging from practice area video filming, through interviews and complete public relations and internet relations management.

Contact Information:
Lawyer Central
Liz Ryan
Tel: 908-222-8848
Email us
Press Release Keywords:

gadolinium attorneys, gadolinium mri, gadolinium contrast, gadolinium lawyer, gadolinium attorney, gadolinium lawsuit

How to buy Penny Stocks
Learn the Skills, Make the Trades, Earn a Fortune! 100% Free to try.
Chartpoppers.com.com




Stop Being Fooled By "Penny Stock Picks"


Subscribe To The #1 Rated MicroCap Stock Newsletter.
MicroCapster.com

 




Analyst Penny Stock Picks


Visit StockSource.us for explosive stock picks, free stock research and trading tools
www.StockSource.us

Your text Ads here!
Ads are only $575 per month. Ads are placed same day. Contac Us

Emailwire.com/contact.php




Press release service and press release distribution on EmailWire.Com is a global newswire of GroupWeb Media LLC.

 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Setup Co-Branding

© Copyright GroupWeb.com 2007